Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > From $0.52 to $28.00 in 12 months or $3.5 to $23 in 3 months

<< Previous

Bullboard Posts

Next >>

Comment by Buckhenryon Jan 12, 2024 11:56am

100 Views

Post# 35823760

RE:RE:RE:RE:RE:RE:RE:From $0.52 to $28.00 in 12 months or $3.5 to $23 in 3 months

Folks just need to understand that assak et al... is in denial. They get quite upset and riot and burn when you upset their narrative. Their only avenue is to attack on a personal level. They are much like a wart on your tushy. It's there but is quite benign.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec